City

Bethesda (1)

Rio de Janeiro (1)

Santa Cruz de la Sierra (1)

Condition

Mucosal Leishmaniasis (3)

Cutaneous Leishmaniasis (1)

Mucocutaneous Leishmaniasis (1)

Overall Status

Completed (1)

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

phase 2 (1)

phase 2/phase 3 (1)

phase 3 (1)

Sponsor

Fundacion Nacional de Dermatologia (1)

Knight Therapeutics (USA) Inc (1)

Oswaldo Cruz Foundation (1)

Collaborator

ABF Foundation for Medical Research (1)

Centro Nacional de Enfermedades Tropicales CENETROP (1)

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (1)

Hospital Dermatologico de Jorochito (1)

Rio de Janeiro State Research Supporting Foundation (FAPERJ) (1)

Intervention

group 1: miltefosine (1)

group 2: pentavalent antimony (1)

group 3: liposomal amphotericin b (1)

meglumine antimoniate (1)

miltefosine (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (3)

mucosal leishmaniasis

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Mucosal Leishmaniasis Trial in Santa Cruz de la Sierra (Group 1: Miltefosine, Group 2: Pentavalent Antimony, Group 3: Liposomal

Recruiting

Mucosal Leishmaniasis

Group 1: Miltefosine
+2 more

Santa Cruz de la Sierra, SC, Bolivia

Hospital Dermatologico de Jorochito

Jun 14, 2022

Mucosal Leishmaniasis, Cutaneous Leishmaniasis Trial run by the USA (Miltefosine)

Completed

Mucosal Leishmaniasis
Cutaneous Leishmaniasis

Miltefosine

Bethesda, Maryland
+1 more

Sep 8, 2020

Mucosal Leishmaniasis, Mucocutaneous Leishmaniasis Trial in Rio de Janeiro (Meglumine antimoniate)

Unknown status

Mucosal Leishmaniasis
Mucocutaneous Leishmaniasis

Meglumine antimoniate

Rio de Janeiro, Brazil

Oswaldo Cruz Foundation - IPEC/FIOCRUZ

Jul 10, 2018